相关实验视频
Updated: May 24, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.2K
在患有帕金森病的患者中,假牙干预的有效性
Prachi Jain1, Manu Rathee1, Arush Bansal2
1Department of Prosthodontics, Post Graduate Institute of Dental Sciences, Pt. B.D. Sharma University of Health Sciences, Rohtak, Haryana, India.
Dental research journal
|March 3, 2025
概括
假肢康复可以改善帕金森病患者的口腔功能和生活质量. 需要进一步的长期研究,以充分评估固定或可拆卸假肢在PD中的影响.
科学领域:
- 牙科 牙科是指牙科的专业.
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 帕金森病 (PD) 显著破坏口腔功能,影响整体健康.
- 假肢康复为患有口腔功能障碍的PD患者提供了一个潜在的解决方案.
- 关于假肢在改善PD患者口腔功能和生活质量 (QoL) 方面的有效性,文献有限.
研究的目的:
- 系统地评估帕金森病患者的假牙康复疗法的有效性.
- 评估固定或可拆卸假肢对PD患者口腔功能和QoL的影响.
主要方法:
- 在PubMed,CINAHL和Google Scholar进行了全面的文献搜索,直至2024年.
- 包含的研究的方法质量是使用既有评估工具 (NOS,跨部门研究的评估工具,JBI批判性评估工具) 进行评估的.
- 在参考列表中进行手动搜索,以确定其他相关文章.
主要成果:
- 总共有9篇文章被纳入了审查.
- 研究分析了口效率 (4篇文章),口腔感知和运动能力 (2篇文章) 以及口腔健康质量 (4篇文章).
- 在一项研究中检查了电肌图学活性.
结论:
- 使用固定或可拆卸的假肢进行假肢康复,对PD患者有潜在的益处,改善口腔功能和QoL.
- 关于评估假肢康复对PD患者口腔功能和QoL的影响,长期研究显著缺乏.
- 需要进一步调查以确定最终的长期结果.
相关概念视频
Parkinson's Disease: Treatment
182
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
182
Parkinson's Disease: Overview
419
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
419

